Spirulina na daya daga cikin manyan ganyen kore da ake sayarwa a sashen kari, kuma wani sabo meta‑analysis ya ba ta damar nuna tasiri a fannin kumburi. Wannan takarda ta taƙaita abin da binciken ya gano, abin da bai gano ba, da kuma wa zai iya amfana da sakamakon.
Sakamakon Takeaway: Spirulina Ta Rage CRP
Masana sun tattara bayanai daga gwaje‑gwajen bazuwar (randomized clinical trials) da suka ba da spirulina ga manyan mutane masu shekaru 18 da sama. Binciken an wallafa shi a International Journal for Vitamin and Nutrition Research a shekarar 2026. Ƙungiyar ta duba Cochrane Library, ClinicalTrials.gov, ISI Web of Science, Scopus da PubMed har zuwa watan Agusta 2025. Gwaje‑gwaje takwas ne suka cika ka’idojin shiga.
An haɗa sakamakon daga waɗannan gwaje‑gwajen, spirulina ta rage matakin serum C‑reactive protein (CRP) idan aka kwatanta da placebo:
- Weighted mean difference: -0.09 mg/L
- 95 % confidence interval: -0.16 zuwa -0.02
Saboda tazara ba ta wuce sifili ba, sakamakon na da muhimmanci na ƙididdiga. CRP alama ce da ake amfani da ita sosai don auna kumburi a jiki, shi ya sa wannan sakamakon ke jan hankalin masu nazari kan “inflammaging”. Wannan kalmar na nufin ƙananan kumburi na dindindin da ake tunanin yana ƙaruwa da shekaru kuma yana ba da gudummawa ga cututtukan da suka shafi tsufa.
Matsala: Ragin Da Ya Yi Ƙanana
Raguwar 0.09 mg/L ba ta da girma sosai. Tazarar amincewa tana farawa daga -0.16 mg/L zuwa -0.02 mg/L. Takardar ba ta bayyana ko wannan canjin yana da tasiri a kan lafiyar mutum ba, kuma ba ta yi ikirarin tasirin cuta ba. Wannan sakamakon alamar dakin gwaji ne, ba hujja da ke nuna spirulina na rage tsufa, hana cutar zuciya ko tsawaita rayuwa ba.
Marubutan sun yi taka tsantsan a kammalawar su. Sun kira a ƙara gwaje‑gwajen RCT masu inganci don tantance amfanin da gaske.
Abinda Ba A Samu Ba: TNF‑α Da IL‑6
Binciken ya kuma dubi wasu alamun kumburi guda biyu. Babu ɗaya daga cikinsu da ya nuna canjin da ya wuce ƙididdiga:
| Marker | Weighted mean difference | 95 % CI |
|---|---|---|
| TNF‑α | -0.43 pg/mL | -1.44 zuwa 0.59 |
| IL‑6 | -0.44 pg/mL | -0.98 zuwa 0.10 |
Duk tazaran sun haɗa da sifili, don haka ba za a iya ƙara da cewa akwai tasiri ba. Tazarar IL‑6 ta kusan wuce sifili kaɗan, wadda ke nuna alama amma ba tabbatacciya ba. Taƙaitaccen bayani shi ne spirulina na da alamar CRP mai muhimmanci amma babu tabbacin tasiri a kan waɗannan cytokines guda biyu.
Kwayoyin Da Lokutan Da Aka Yi Amfani Da Su A Gwaje‑gwajen
Takardar ta ba da jerin iyakokin da aka yi amfani da su a gwaje‑gwajen takwas:
- Dose: 1 g zuwa 8 g a rana
- Tsawon lokaci: makonni 3 zuwa 16
Wannan ya nuna bambanci sosai. Takardar ba ta raba sakamakon bisa dose ko tsawon lokaci ba, don haka ba ta gaya mana wane dose ne ya fi tasiri ko ko manyan dose za su fi amfani. Har ila yau ba ta tabo lokacin cin ko shan spirulina, ko wane nau’i ne ya fi dacewa. Abin da aka samu a zahiri shi ne gwaje‑gwajen sun yi amfani da 1‑8 g a rana, tsawon makonni kaɗan zuwa watanni.
Wa Ya Dace Da Wannan?
Binciken ya shafi manyan mutane masu shekaru 18 da sama, kuma ba a ware wani yanayi na lafiya ko ƙungiya ba. Don haka ba za a karanta shi a matsayin shawara ga kowane rukuni ba. Ga wasu muhimman abubuwa:
- Mutanen da ke sha'awar hanyoyin abinci don rage kumburi na iya amfani da sakamakon CRP a matsayin hujja ga likita, a matsayin zaɓi mai ƙarancin haɗari a cikin dabarun rayuwa. Takardar ba ta tantance aminci ko illa ba, don haka “ƙarancin haɗari” ra'ayi ne, ba hujja ba.
- Mutanen da ke da CRP mai ɗaga ko yanayin kumburi su guji ɗaukar spirulina a matsayin madadin maganin likita. Binciken bai gwada shi a wannan yanayin ba.
- Mutanen da ke shan magani ko da cuta su tattauna da ƙwararren likita kafin su fara wani sabon kari.
Dalilin Da Ya Sa Ya Kamata Ka Yi Caution
Babban gargadi yana cikin takardar kanta: heterogeneity ya kasance mai girma a dukkanin alamun da aka nazarta. A sauƙaƙe, gwaje‑gwajen sun yi bambanci da juna fiye da yadda bazuwar zata iya bayyana. Wannan na iya fitowa daga bambancin dose, tsawon lokaci, lafiyar mahalarta, ingancin samfurin spirulina ko tsarin gwaji. Marubutan sun yi amfani da random‑effects model (DerSimonian and Laird), wanda ke ɗaukar wani ɓangare na wannan bambanci, amma ba ya magance shi gaba ɗaya.
Sauran iyakoki da ya kamata a tuna su:
- Ƙaramin tushe na hujja. Gwaje‑gwajen takwas ba su da yawa, kuma takardar ba ta ba da adadin mahalarta ko kimantawa na haɗarin bias ba.
- Alama, ba sakamako ba. Rage CRP ba yana nufin lafiyar jiki za ta inganta kai tsaye ba.
- Sakamako masu gauraye a tsakanin alamu. Kawai CRP ya kai ga muhimmanci.
- Babu bayanan dose‑to‑dose a takardar don jagorantar yawan da za a sha.
Binciken an yi rijista a PROSPERO (CRD42024606496), wanda ke ƙara bayyana gaskiya.
Kammalawa
Spirulina ta sami amincewa mai takaitaccen “thumbs‑up” kan CRP. Meta‑analysis ya gano raguwar da ta yi ƙididdiga amma ƙarami (-0.09 mg/L) idan aka kwatanta da placebo, tare da dose na 1 zuwa 8 g a rana tsawon makonni 3 zuwa 16. Ba a samu tasiri mai muhimmanci kan TNF‑α ko IL‑6 ba, kuma heterogeneity tsakanin gwaje‑gwajen ya kasance mai girma. Saboda haka, spirulina ya fi dacewa a ɗauke shi a matsayin ƙari mai alƙawari amma ba a tabbatar da tasirinsa wajen rage kumburi ko anti‑aging ba. Gwaje‑gwajen manya‑manya da aka tsara sosai za su nuna ko wannan alamar ƙanana za ta tsaya ƙarfi.